|
|
| Research article summary (published 29 Jun 2002): |
Novel skeletal muscle ryanodine receptor mutation in a large Brazilian family with malignant hyperthermia.
Full Abstract
Malignant hyperthermia (MH) is an autosomal dominant disorder that predisposes susceptible individuals to a potentially life-threatening crisis when exposed to commonly used anesthetics. Mutations in the skeletal muscle calcium release channel, ryanodine receptor (RYR1) are associated with MH in over 50% of affected families. Linkage analysis of the RYR1 gene region at 19q13 was performed in a large Brazilian family and a distinct disease co-segregating haplotype was revealed in the majority of members with diagnosis of MH. Subsequent sequencing of RYR1 mutational hot spots revealed a nucleotide substitution of C to T at position 7062, causing a novel amino acid change from Arg2355 to Cys associated with MH in the family. Haplotype analysis of the RYR1 gene area at 19q13 in the family with multiple MH members is an important tool in identification of genetic cause underlying this disease.
Author information
Author/s: McWilliams, S (S); Nelson, T (T); Sudo, R T (RT); Zapata-Sudo, G (G); Batti, M (M); Sambuughin, N (N);
Affiliation: Department of Neurology Research, Barrow Neurological Institute, 350 W Thomas Road, Phoenix, AZ 85013, USA.
Journal and publication information
Publication Type: Journal Article
Journal: Clinical genetics (Clin Genet), published in Denmark. (Language: eng)
Reference: 2002-Jul; vol 62 (issue 1) : pp 80-3
Dates: Created 2002/07/18; Completed 2003/02/12; Revised 2004/11/17;
PMID: 12123492, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Ryanodine Receptor Calcium Release Channel (0)Related articles
These are the most related articles currently in our database:
- An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
30 Oct 2000 - Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
30 Dec 2002 - RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
30 Jul 2002 - Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
30 Oct 2005 - [Malignant hyperthermia. The ugly]
30 Aug 2007 - Novel ryanodine receptor mutation that may cause malignant hyperthermia.
30 Aug 2008 - Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation.
30 Jul 2002 - [Malignant hyperthermia]
13 Sep 2003 - Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
29 Sep 1997
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.